HSP90AB1 and neoplasm: The individual and combined efficacies of Hsp90ab1 and Eno1 recombinant proteins were plotted in the concentration range of 1 ng/mL to 5 μg/mL, showing their additive anti-tumor effects on MTT-based tumor viability (Figure 7E).